Designed for peripheral angioplasty procedures,, the company is making this product available for distribution in the coming months.
Surmodics .014" PTA balloon catheter leverages the company's proprietary Serenehydrophilic coating, unmatched for low friction and particulates.
Its proprietary balloon and catheter technology, combined with Surmodics' advanced processes, ensures ultra-low tip entry and crossing profile with smooth transitions, to achieve best-in-class product performance.
With a complete suite of in-house capabilities at its state-of-the-art facility in Ballinasloe, Ireland, Surmodics controls every step of the manufacturing process to produce high-quality, reliable balloon catheters under rigorous testing.
Surmodics develops surface modification technologies for intravascular medical devices and provides chemical components for in vitro diagnostic (IVD) tests and microarrays.
Following acquisitions of Creagh Medical and NorMedix, the company is expanding to offer total intravascular product solutions to its medical device customers.
The company's mission is to improve the detection and treatment of disease.
Halma acquires Rovers Medical Devices
boston Scientific granted FDA approval for AGENT Drug-Coated Balloon
Enable Injections names new chief operating officer
BridgeBio Pharma and Kyowa Kirin partner on infigratinib for skeletal dysplasias in Japan
Redwood Scientific signs agreement with Jeeva Clinical Trials
Tissue Regenix ships first allograft products in the EU post-HPRA approval
Kromek secures GBP1.3m grant for AI-powered radiation sensor project